Ash Bullement
- Economics and Econometrics top 5%
- Health Systems, Economic Evaluations, Quality of Life 26
- Economic and Financial Impacts of Cancer 12
- Pharmaceutical Economics and Policy 7
- Statistics and Probability top 10%
- Statistical Methods in Clinical Trials 6
-
- Polyomavirus and related diseases 4
-
- Hemophilia Treatment and Research 3
-
- Esophageal Cancer Research and Treatment 3
-
- Healthcare cost, quality, practices 3
Ash Bullement
42 papers receiving 429 citations
Peers
Comparison fields: 5 of 78
- Economics and Econometrics 194
- Statistics and Probability 46
- Oncology 138
- Hematology 41
- Pulmonary and Respiratory Medicine 74
Countries citing papers authored by Ash Bullement
This map shows the geographic impact of Ash Bullement's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ash Bullement with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ash Bullement more than expected).
Fields of papers citing papers by Ash Bullement
This network shows the impact of papers produced by Ash Bullement. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ash Bullement. The network helps show where Ash Bullement may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ash Bullement, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 2 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 3 | |
| 10 | 2020 | 35 | |
| 11 | 2020 | 6 | |
| 12 | 2019 | 12 | |
| 13 | 2019 | 19 | |
| 14 | 2019 | 7 | |
| 15 | 2019 | 2 | |
| 16 | 2018 | 22 | |
| 17 | 2018 | 53 | |
| 18 | 2018 | 1 | |
| 19 | 2017 | 2 | |
| 20 | 2016 | 1 |
About Ash Bullement
Ash Bullement is a scholar working on Economics and Econometrics, Statistics and Probability and Hematology, having authored 46 papers that have together received 437 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (26 papers), Economic and Financial Impacts of Cancer (12 papers), Pharmaceutical Economics and Policy (7 papers), Statistical Methods in Clinical Trials (6 papers), Polyomavirus and related diseases (4 papers), Esophageal Cancer Research and Treatment (3 papers), Hemophilia Treatment and Research (3 papers) and Healthcare cost, quality, practices (3 papers). The work is most often cited by research in Economics and Econometrics (194 citations), Statistics and Probability (46 citations) and Oncology (138 citations). Ash Bullement has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Anthony J. Hatswell, Gemma Shields, Nicholas Latimer, Matt Stevenson, Mike Paulden, Andrew Briggs, Murtuza Bharmal, Ronan Fougeray, Jamie Elvidge and Dawn Lee. Their work appears in journals such as Value in Health, PharmacoEconomics, Journal of Medical Economics, Applied Health Economics and Health Policy and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.